Related Experiment Video
Updated: Jun 5, 2026
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
TSP-1 in lung fibrosis.
1Medical Sciences Building, University of Western Ontario, London, ON N6A 5C1 Canada.
Journal of Cell Communication and Signaling
|January 15, 2011
Summary
Thrombospondin-1 (TSP-1) deficiency surprisingly worsens lung fibrosis in mice, contrary to expectations. TSP-1-null mice showed increased fibrosis after bleomycin challenge, despite similar TGFβ signaling.
Area of Science:
- Pulmonary Medicine
- Fibrosis Research
- Immunology
Background:
- Lung fibrosis lacks effective treatments beyond managing inflammation.
- Transforming growth factor beta (TGFβ) is a key cytokine in fibrotic processes.
- Thrombospondin-1 (TSP-1) activates TGFβ, suggesting TSP-1 deficiency might be protective.
Purpose of the Study:
- To investigate the role of TSP-1 in bleomycin-induced lung fibrosis.
- To determine if TSP-1 deficiency protects mice from pulmonary fibrosis.
Main Methods:
- Bleomycin-induced lung fibrosis model in TSP-1 deficient mice and wild-type controls.
- Assessment of lung fibrosis severity.
- Analysis of TGFβ signaling pathways.
Main Results:
- TSP-1 deficient mice exhibited exacerbated lung fibrosis compared to wild-type mice.
- No significant difference in TGFβ signaling was observed between TSP-1 deficient and wild-type mice.
- Contrary to hypothesis, TSP-1 deficiency did not protect against bleomycin-induced pulmonary fibrosis.
Conclusions:
- TSP-1 deficiency exacerbates, rather than protects against, bleomycin-induced lung fibrosis.
- The role of TSP-1 in pulmonary fibrosis is complex and warrants further investigation.
- Novel therapeutic targets for lung fibrosis may need to consider TSP-1's multifaceted functions.
